Xiao-ping Chen
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- Cancer-related gene regulation
- RNA Research and Splicing
Papers in
-
- Cancer-related molecular mechanisms research 18
- Cancer, Hypoxia, and Metabolism 12
- MicroRNA in disease regulation 6
-
- RNA modifications and cancer 18
- Cancer-related gene regulation 8
- RNA Research and Splicing 6
- Circular RNAs in diseases 4
- Co-authors
- Bixiang Zhang (26 shared papers)Zhibin Liao (12 shared papers)Limin Xia (9 shared papers)Bixiang Zhang (5 shared papers)Mengyu Sun (8 shared papers)Wenjie Huang (8 shared papers)Yijun Wang (6 shared papers)Qibo Huang (2 shared papers)
- Journals
- Signal Transduction and Targeted Therapy (3 papers)Oncogene (3 papers)Cell Death Discovery (3 papers)Cell Death and Disease (3 papers)Biomarker Research (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiao-ping Chen
87 papers receiving 1.9k citations
Xiao-ping Chen's Hit Papers
Peers
Comparison fields: 5 of 122
- Cancer Research 566
- Molecular Biology 958
- Immunology 222
- Oncology 269
- Hepatology 57
Countries citing papers authored by Xiao-ping Chen
This map shows the geographic impact of Xiao-ping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao-ping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao-ping Chen more than expected).
Fields of papers citing papers by Xiao-ping Chen
This network shows the impact of papers produced by Xiao-ping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao-ping Chen. The network helps show where Xiao-ping Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiao-ping Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 138 | |
| 2 | 2022 | 100 | |
| 3 | 2010 | 94 | |
| 4 | 2023 | 83 | |
| 5 | 2022 | 76 | |
| 6 | 2010 | 67 | |
| 7 | 2014 | 64 | |
| 8 | 2022 | 56 | |
| 9 | Cancer stem cells and niches: challenges in immunotherapy resistance Hit paper breakdown → | 2025 | 55 |
| 10 | 2022 | 51 | |
| 11 | 2014 | 47 | |
| 12 | 2022 | 45 | |
| 13 | 2021 | 42 | |
| 14 | 2010 | 40 | |
| 15 | 2022 | 40 | |
| 16 | 2022 | 34 | |
| 17 | 2021 | 31 | |
| 18 | 2019 | 31 | |
| 19 | 2018 | 30 | |
| 20 | 2016 | 29 |
About Xiao-ping Chen
Xiao-ping Chen is a scholar working on Cancer Research, Molecular Biology, Hepatology, Oncology and Immunology, having authored 94 papers that have together received 1.9k indexed citations. Recurring topics across this work include RNA modifications and cancer (18 papers), Cancer-related molecular mechanisms research (18 papers), Cancer, Hypoxia, and Metabolism (12 papers), Cancer-related gene regulation (8 papers), RNA Research and Splicing (6 papers), MicroRNA in disease regulation (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Circular RNAs in diseases (4 papers). The work is most often cited by research in Cancer Research (566 citations), Molecular Biology (958 citations), Immunology (222 citations), Oncology (269 citations) and Hepatology (57 citations). Xiao-ping Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Bixiang Zhang, Zhibin Liao, Limin Xia, Bixiang Zhang, Mengyu Sun, Wenjie Huang, Yijun Wang, Qibo Huang, Tongyue Zhang and Danfei Liu. Their work appears in journals such as Signal Transduction and Targeted Therapy, Oncogene, Cell Death Discovery, Cell Death and Disease and Biomarker Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.